Arteris Sees Q3 Sales $24.000M-$25.000M vs $23.415M Est
Arteris (NASDAQ:AIP) sees Q3 sales of $24.000 million-$25.000 million vs $23.415 million analyst estimate.
Read original at benzingaStocks · News reference
Jefferies Upgrades Arteris to Buy, Raises Price Target to $50
Jefferies analyst Kevin Garrigan upgrades Arteris (NASDAQ:AIP) from Hold to Buy and raises the price target from $35 to $50.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 8, 2026, 12:27 AM
- Checked
- Aug 8, 2026, 12:27 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Arteris Raises FY2026 Sales Guidance from $91.000M-$95.000M to $95.000M-$98.000M vs $94.578M Est
Arteris (NASDAQ:AIP) raises FY2026 sales outlook from $91.000 million-$95.000 million to $95.000 million-$98.000 million vs $94.578 million estimate.
Read original at benzingaArteris Q2 Adj. EPS $(0.10) Misses $(0.04) Estimate, Sales $24.134M Beat $23.482M Estimate
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.04) by 150 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same
Read original at benzinga